- Home
- NAZ vs BDSX Comparison
NAZ vs BDSX Comparison
Compare NAZ & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAZ
- BDSX
- Stock Information
- Founded
- NAZ 1992
- BDSX 2005
- Country
- NAZ United States
- BDSX United States
- Employees
- NAZ N/A
- BDSX N/A
- Industry
- NAZ Finance/Investors Services
- BDSX Precision Instruments
- Sector
- NAZ Finance
- BDSX Health Care
- Exchange
- NAZ Nasdaq
- BDSX Nasdaq
- Market Cap
- NAZ 133.9M
- BDSX 115.4M
- IPO Year
- NAZ N/A
- BDSX 2020
- Fundamental
- Price
- NAZ $11.61
- BDSX $0.27
- Analyst Decision
- NAZ
- BDSX Strong Buy
- Analyst Count
- NAZ 0
- BDSX 5
- Target Price
- NAZ N/A
- BDSX $1.75
- AVG Volume (30 Days)
- NAZ 18.3K
- BDSX 1.9M
- Earning Date
- NAZ 01-01-0001
- BDSX 08-06-2025
- Dividend Yield
- NAZ 3.69%
- BDSX N/A
- EPS Growth
- NAZ N/A
- BDSX N/A
- EPS
- NAZ N/A
- BDSX N/A
- Revenue
- NAZ N/A
- BDSX $74,463,000.00
- Revenue This Year
- NAZ N/A
- BDSX $17.29
- Revenue Next Year
- NAZ N/A
- BDSX $29.33
- P/E Ratio
- NAZ N/A
- BDSX N/A
- Revenue Growth
- NAZ N/A
- BDSX 35.76
- 52 Week Low
- NAZ $9.22
- BDSX $0.17
- 52 Week High
- NAZ $11.37
- BDSX $2.04
- Technical
- Relative Strength Index (RSI)
- NAZ 44.14
- BDSX 40.76
- Support Level
- NAZ $11.49
- BDSX $0.25
- Resistance Level
- NAZ $11.72
- BDSX $0.28
- Average True Range (ATR)
- NAZ 0.16
- BDSX 0.02
- MACD
- NAZ 0.01
- BDSX 0.00
- Stochastic Oscillator
- NAZ 22.97
- BDSX 33.37
About NAZ Nuveen Arizona Quality Municipal Income Fund
Nuveen Arizona Quality Municipal Income Fund is a closed-end management investment company. Its primary investment objective is to provide current income exempt from both regular federal income taxes and Arizona individual income taxes. The fund's secondary objective is to enhance the portfolio value relative to the Arizona municipal bond market through investments in tax-exempt Arizona Municipal Obligations that, in the opinion of the Fund's investment adviser, are underrated or undervalued or represent municipal market sectors that are undervalued.
About BDSX Biodesix Inc.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.